MFEC:PA:PA-Lyxor Core MSCI EMU (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 13.728

Change

-0.08 (-0.59)%

Market Cap

USD 0.48B

Volume

39.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.17 (+0.37%)

USD 64.63B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.80 (-0.16%)

USD 12.31B
WRD:PA HSBC ETFs Public Limited Compa..

-0.03 (-0.10%)

USD 10.00B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.82 (+0.34%)

USD 8.21B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-3.80 (-0.89%)

USD 7.68B
HHH:PA HSBC ETFs Public Limited Compa..

-0.06 (-0.12%)

USD 6.94B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.26 (-0.08%)

USD 6.61B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.01 (-0.06%)

USD 6.11B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.44 (-0.12%)

USD 4.66B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-0.22 (-0.15%)

USD 4.44B

ETFs Containing MFEC:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.58% 58% F 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.58% 51% F 66% D+
Trailing 12 Months  
Capital Gain 13.70% 50% F 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.70% 73% C 65% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.56% 62% D 63% D
Dividend Return 8.56% 62% D 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.16% 67% D+ 83% B
Risk Adjusted Return 104.89% 99% N/A 97% N/A
Market Capitalization 0.48B 68% D+ 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike